Physician

Holly A Ward, MD

According to 2025 Medicare claims, Holly Ward, MD (NPI: 1487619078) practices dermatology in the Crestview-Fort Walton Beach-Destin, FL market, with the plurality of this provider's patient population coming from Okaloosa, FL. Ward uses personal NPI as billing NPI and primary practice location at 32579-1304.

Ward's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,675 traditional Medicare patients, billed 17,409 HCPCS/CPT codes, and received $770,684 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 706 prescription claims across 302 beneficiaries totaling $329,288 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 7 records totaling $182. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $35,866 to $329,288. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$538K$1.1M2015 Medicare payment: $832,559 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $911,819 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $898,357 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $934,092 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,076,006 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $910,614 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $963,425 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $896,809 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $857,853 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $770,684 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,49615,489$832,559
20161,55518,030$911,819
20171,62217,735$898,357
20181,78617,819$934,092
20191,99120,224$1,076,006
20201,83118,500$910,614
20211,81318,753$963,425
20221,72418,427$896,809
20231,73917,262$857,853
20241,67517,409$770,684

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$166K$332K2015 Drug cost: $35,866 (USD; Tot_Drug_Cst)2016 Drug cost: $42,817 (USD; Tot_Drug_Cst)2017 Drug cost: $44,734 (USD; Tot_Drug_Cst)2018 Drug cost: $42,795 (USD; Tot_Drug_Cst)2019 Drug cost: $28,027 (USD; Tot_Drug_Cst)2020 Drug cost: $93,174 (USD; Tot_Drug_Cst)2021 Drug cost: $194,025 (USD; Tot_Drug_Cst)2022 Drug cost: $331,858 (USD; Tot_Drug_Cst)2023 Drug cost: $293,038 (USD; Tot_Drug_Cst)2024 Drug cost: $329,288 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015164342$35,866
2016170439$42,817
2017202502$44,734
2018245577$42,795
2019218473$28,027
2020224514$93,174
2021211507$194,025
2022255599$331,858
2023226555$293,038
2024302706$329,288

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths533717$72
11102Biopsy of related skin growth, first growth630823$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,4032,377$59
17000Destruction of precancer skin growth, 1 growth1,0941,906$37
17003Destruction of precancer skin growth, 2-14 growths9188,429$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab34963$236,785
Dupixent PenDupilumab12336$44,631
FluorouracilFluorouracil461,328$3,192
Tetracycline HclTetracycline Hcl66686$3,141
Clobetasol PropionateClobetasol Propionate30752$1,532

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$182Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Holly A. Ward, MD?

Tedicare shows public-source Medicare data for Holly A. Ward, MD (NPI 1487619078), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Holly A. Ward, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Holly A. Ward, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Holly A. Ward, MD have Open Payments data?

Holly A. Ward, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.